Does vaccination with 4CMenB convey protection against meningococcal serogroup B strains not predicted to be covered by MATS? A study of the UK clonal complex cc269.
4CMenB
Neisseria meningitidis
meningococcal B vaccine
meningococcal antigen typing system
meningococcus serogroup B
serum bactericidal antibody assay
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
02 04 2020
02 04 2020
Historique:
pubmed:
27
11
2019
medline:
22
6
2021
entrez:
27
11
2019
Statut:
ppublish
Résumé
The Meningococcal Antigen Typing System (MATS) has been developed as an hSBA surrogate to evaluate potential coverage afforded by the 4-component meningococcal serogroup B vaccine (4CMenB:
Identifiants
pubmed: 31770063
doi: 10.1080/21645515.2019.1688039
pmc: PMC7227617
doi:
Substances chimiques
Antigens, Bacterial
0
Meningococcal Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
945-948Références
Vaccine. 2013 Oct 9;31(43):4968-74
pubmed: 23954380
Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19490-5
pubmed: 20962280
Clin Diagn Lab Immunol. 2005 Aug;12(8):970-6
pubmed: 16085915
Lancet. 2016 Dec 3;388(10061):2775-2782
pubmed: 28100432
Sci Rep. 2018 Feb 27;8(1):3700
pubmed: 29487324
Vaccine. 2011 Feb 24;29(10):1968-73
pubmed: 21241734
Lancet Infect Dis. 2017 Jul;17(7):754-762
pubmed: 28366725
J Exp Med. 1969 Jun 1;129(6):1327-48
pubmed: 4977281
J Exp Med. 1969 Jun 1;129(6):1307-26
pubmed: 4977280
Pediatr Infect Dis J. 2016 Apr;35(4):e113-23
pubmed: 26756390
Vaccine. 2016 May 17;34(23):2579-84
pubmed: 27083425
Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10834-9
pubmed: 16825336
Lancet. 2013 Mar 9;381(9869):825-35
pubmed: 23324563
Clin Vaccine Immunol. 2012 Oct;19(10):1609-17
pubmed: 22875603
JAMA. 2012 Feb 8;307(6):573-82
pubmed: 22318278